Bernard (barry) Baumel
Clinical trials sponsored by Bernard (barry) Baumel, explained in plain language.
-
Could one stem cell infusion slow Alzheimer's decline?
Disease control Recruiting nowThis study tests whether adding a single infusion of human stem cells to standard antibody therapy can slow memory and thinking decline in people with mild Alzheimer's or mild cognitive impairment. Ten participants aged 55-90 who are already on antibody treatment will receive one…
Phase: PHASE2 • Sponsor: Bernard (Barry) Baumel • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could stem cells tame Alzheimer's agitation? new pilot study seeks answers
Symptom relief Recruiting nowThis small pilot study is testing whether a single infusion of human mesenchymal stem cells can help control agitation, aggression, and other behavioral symptoms in people with moderate to severe Alzheimer's disease. The study involves 8 adults aged 55-90 who are already taking a…
Phase: PHASE2 • Sponsor: Bernard (Barry) Baumel • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC